Literature DB >> 26661374

CD1a+ and CD83+ Langerhans cells are reduced in lower lip squamous cell carcinoma.

Juliane Oliveira Gomes1, Marianne de Vasconcelos Carvalho2, Felipe Paiva Fonseca1, Rogério Oliveira Gondak3, Márcio Ajudarte Lopes1, Pablo Agustin Vargas1,4.   

Abstract

BACKGROUND: Actinic cheilitis (AC) is a potentially malignant lesion diagnosed in the lip of patients chronically exposed to the sun that may give rise to a fully invasive lower lip squamous cell carcinoma (LLSCC). It is known that ultraviolet radiation causes dendritic cells (DCs) depletion in the epidermis, but the role of this cellular population in lip cancer progression remains uncertain. Therefore, this study investigated the distribution of DCs in normal, dysplastic and neoplastic tissues of the lower lip.
METHODS: Thirteen cases of lower lip mucocele, 42 of ACs and 21 of LLSCC were retrieved and original diagnoses confirmed by two oral pathologists, who further classified ACs as low- and high-risk lesions. Immunoreactions against CD1a and CD83 identified immature and mature DCs, respectively.
RESULTS: Immature CD1a+ Langerhans cells (LCs) were significantly decreased in LLSCC when compared to morphologically normal (P < 0.009) and dysplastic epitheliums (P < 0.003), whereas mature CD83+ LCs were significantly decreased in LLSCC when compared to normal epithelium (P = 0.038). There was no significant difference between low- and high-risk ACs regarding CD1a+ and CD83+ LCs (P > 0.05), but ACs demonstrated a lower concentration of CD1a+ LCs than normal epithelium (P < 0.009). There was no significant difference in the distribution of CD1a+ and CD83+ interstitial dendritic cells (IDCs) in the connective tissue among the studied groups (P > 0.05).
CONCLUSION: These results suggest that depletion of epithelial LCs, but not IDCs in the connective tissue, would represent an important step for lip cancer development.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CD1a; CD83; Langerhans cells; actinic cheilitis; lip squamous cell carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26661374     DOI: 10.1111/jop.12389

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

1.  Decreased CD1a + and CD83 + cells in tonsillar squamous cell carcinoma regardless of HPV status.

Authors:  Ana Guadalupe Gama-Cuellar; Ana Lúcia Noronha Francisco; João Figueira Scarini; Fernanda Viviane Mariano; Luiz Paulo Kowalski; Rogério Gondak
Journal:  J Appl Oral Sci       Date:  2022-05-16       Impact factor: 3.144

2.  Increased Tumor Immune Microenvironment CD3+ and CD20+ Lymphocytes Predict a Better Prognosis in Oral Tongue Squamous Cell Carcinoma.

Authors:  Raísa Sales de Sá; Marisol Miranda Galvis; Bruno Augusto Linhares Almeida Mariz; Amanda Almeida Leite; Luciana Schultz; Oslei Paes Almeida; Alan Roger Santos-Silva; Clovis Antonio Lopes Pinto; Pablo Agustin Vargas; Kenneth John Gollob; Luiz Paulo Kowalski
Journal:  Front Cell Dev Biol       Date:  2021-02-18

3.  Density of Langerhans Cells in Nonmelanoma Skin Cancers: A Systematic Review.

Authors:  Joanna Pogorzelska-Dyrbuś; Jacek C Szepietowski
Journal:  Mediators Inflamm       Date:  2020-04-19       Impact factor: 4.711

4.  CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma.

Authors:  L-C Silva; F-P Fonseca; O-P Almeida; B-A Mariz; M-A Lopes; R Radhakrishnan; M Sharma; L-P Kowalski; P-A Vargas
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01

5.  Can immunohistochemical biomarkers distinguish epithelial dysplasia degrees in actinic cheilitis? A systematic review and meta-analysis.

Authors:  T Santana; B Matuck; J-R Tenório; M-M Braga
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.